In the 123 triple-negative FMCs, Sox2 expression showed a positive association with the clinical tumor size, dermal infiltration, the Ki-67 proliferation index, AR expression, and intratumoral Treg numbers (Supplementary Tables 4, 5). The gene discussed is SOX2; the disease is neoplasm.